Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Iterum Therapeutics plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $76.16M | $76.16M - $76.16M | $0.00 | $0.14 | 1 |
| Dec 2028 | $48.73M | $48.73M - $48.73M | $0.00 | -$0.19 | 1 |
| Dec 2027 | $41.35M | $41.35M - $41.35M | $0.00 | -$0.41 | 1 |
| Dec 2026 | $9.38M | $9.38M - $9.38M | $0.00 | -$0.31 | 1 |
| Dec 2025 | $895.0K | $895.0K - $895.0K | $0.00 | -$0.66 | 1 |
| Dec 2024 | $3.02M | $3.02M - $3.02M | $0.00 | -$1.15 | 1 |
| Dec 2023 | $779.0K | $751.4K - $806.6K | $0.00 | -$2.955 | 1 |
| Dec 2019 | $74.8K | $72.1K - $77.5K | $0.00 | -$108.00 | 1 |
| Dec 2018 | $856.0K | $825.7K - $886.3K | $0.00 | -$143.01 | 1 |